These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9745505)

  • 1. Role of CD8+ and CD4+ T cells in the rejection of murine intestinal allografts.
    He G; Hart J; Thistlethwaite JR; Newell KA
    Transplant Proc; 1998 Sep; 30(6):2592-3. PubMed ID: 9745505
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of intestinal allograft rejection by an anti-CD8 monoclonal antibody is not mediated by depletion alone.
    He G; Hart J; Thistlethwaite JR; Newell KA
    Transplant Proc; 1998 Jun; 30(4):1069-70. PubMed ID: 9636433
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment with either anti-CD4 or anti-CD8 monoclonal antibodies blocks alphabeta T cell-mediated rejection of intestinal allografts in mice.
    Newell KA; He G; Hart J; Thistlethwaite JR
    Transplantation; 1997 Oct; 64(7):959-65. PubMed ID: 9381541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indirect allorecognition is involved in both acute and chronic allograft rejection.
    Fluck N; Witzke O; Morris PJ; Wood KJ
    Transplant Proc; 1999; 31(1-2):842-3. PubMed ID: 10083366
    [No Abstract]   [Full Text] [Related]  

  • 5. Differential effect of an anti-CD8 monoclonal antibody on rejection of murine intestine and cardiac allografts.
    He G; Kim OS; Thistlethwaite JR; Hart J; Siegel CT; Szot GL; Newell KA
    Transplant Proc; 1999; 31(1-2):1239-41. PubMed ID: 10083553
    [No Abstract]   [Full Text] [Related]  

  • 6. Tissue-specific immune response: the role of innate immunity in small bowel and heart transplantation.
    Dresske B; Zavazava N; Brötzmann K; Kremer B; Fändrich F
    Transplant Proc; 1998 Sep; 30(6):2566-7. PubMed ID: 9745490
    [No Abstract]   [Full Text] [Related]  

  • 7. Effector cells must recognize antigens expressed in the graft to cause efficient skin graft rejection in SCID mice.
    Wecker H; Grusby MJ; Auchincloss H
    Transplantation; 1995 Apr; 59(8):1223-7. PubMed ID: 7732570
    [No Abstract]   [Full Text] [Related]  

  • 8. An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection.
    Haskova Z; Sproule TJ; Roopenian DC; Ksander AB
    Transplantation; 2003 Apr; 75(8):1368-74. PubMed ID: 12717232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of CD8 and CD4 T cells in intestinal allograft rejection: a comparison of monoclonal antibody-treated and knockout mice.
    He G; Hart J; Kim OS; Szot GL; Siegel CT; Thistlethwaite JR; Newell KA
    Transplantation; 1999 Jan; 67(1):131-7. PubMed ID: 9921809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of selective immunosuppression with FK 506, anti-IL-2R, and anti-ICAM-1 MAb in rat small bowel transplantation.
    Gasser M; Timmermann W; Vowinkel T; Tykal K; Hoppe H; Otto C; Gassel AM; Meyer D; Ulrichs K; Thiede A
    Transplant Proc; 1998 Sep; 30(6):2605-6. PubMed ID: 9745510
    [No Abstract]   [Full Text] [Related]  

  • 11. Blockade of the CD40 pathway fails to prevent CD8 T cell-mediated intestinal allograft rejection.
    Meng L; Guo Z; Kim O; He G; Hart J; Szot GL; Wang J; Pearson TC; Larsen CP; Newell KA
    Transplant Proc; 2001; 33(1-2):418-20. PubMed ID: 11266891
    [No Abstract]   [Full Text] [Related]  

  • 12. CD8+ lymphocytes augment chronic rejection in a MHC class II mismatched model.
    Fischbein MP; Yun J; Laks H; Irie Y; Fishbein MC; Espejo M; Bonavida B; Ardehali A
    Transplantation; 2001 Apr; 71(8):1146-53. PubMed ID: 11374417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of host T cell subsets in bone marrow rejection directed to isolated major histocompatibility complex class I versus class II differences of bm1 and bm12 mutant mice.
    Vallera DA; Taylor PA; Sprent J; Blazar BR
    Transplantation; 1994 Jan; 57(2):249-56. PubMed ID: 7906058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts: role of interferon-gamma.
    Nagano H; Libby P; Taylor MK; Hasegawa S; Stinn JL; Becker G; Tilney NL; Mitchell RN
    Am J Pathol; 1998 May; 152(5):1187-97. PubMed ID: 9588888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+ but not CD8+ cells are essential for allorejection.
    Krieger NR; Yin DP; Fathman CG
    J Exp Med; 1996 Nov; 184(5):2013-8. PubMed ID: 8920888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered intragraft immune responses and improved renal function in MHC class II-deficient mouse kidney allografts.
    Mannon RB; Doyle C; Griffiths R; Bustos M; Platt JL; Coffman TM
    Transplantation; 2000 May; 69(10):2137-43. PubMed ID: 10852613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II.
    Pietra BA; Wiseman A; Bolwerk A; Rizeq M; Gill RG
    J Clin Invest; 2000 Oct; 106(8):1003-10. PubMed ID: 11032860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic rejection of murine cardiac allografts discordant at the H13 minor histocompatibility antigen correlates with the generation of the H13-specific CD8+ cytotoxic T cells.
    Yang J; Jaramillo A; Liu W; Olack B; Yoshimura Y; Joyce S; Kaleem Z; Mohanakumar T
    Transplantation; 2003 Jul; 76(1):84-91. PubMed ID: 12865791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Despite high levels of lymphocyte homing receptor alpha4beta7 integrin after small bowel allotransplantation, it is not critical for rejection.
    Kellersmann R; Zhong R; Grant D; Garcia B; Blömer A; Liu W; Wagner N; Müller W; Jevnikar A; Thiede A; Lazarovits A
    Transplant Proc; 2000 Sep; 32(6):1267-8. PubMed ID: 10995941
    [No Abstract]   [Full Text] [Related]  

  • 20. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
    Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
    Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.